img

Global Gemtuzumab Ozogamicin Drugs Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gemtuzumab Ozogamicin Drugs Market Insights, Forecast to 2034

Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010.
Global Gemtuzumab Ozogamicin Drugs market is expected to reach to US$ 208.9 million in 2024, with a positive growth of %, compared with US$ 214.3 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Gemtuzumab Ozogamicin Drugs industry is evaluated to reach US$ 179.5 million in 2029. The CAGR will be -2.5% during 2024 to 2029.
Gemtuzumab Ozogamicin is an antibody-drug conjugate used to treat certain types of acute myeloid leukemia (AML). Its efficacy in targeting CD33-expressing AML cells and inducing remission has driven market growth. The limited treatment options for CD33-positive AML contribute to its niche status. However, challenges include potential side effects and the need for careful patient selection. The market competition is relatively small, as Gemtuzumab Ozogamicin remains a targeted therapy for a specific AML subgroup. Despite challenges, the Gemtuzumab Ozogamicin market offers potential for growth as healthcare providers seek effective treatments for patients with CD33-positive AML. Continued research and clinical advancements can further drive market expansion.
Report Covers
This report presents an overview of global Gemtuzumab Ozogamicin Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Gemtuzumab Ozogamicin Drugs market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Segment by Type
5mg/Vial
4.5mg/Vial

Segment by Application


Hospital
Pharmacy

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Gemtuzumab Ozogamicin Drugs plant distribution, commercial date of Gemtuzumab Ozogamicin Drugs, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Gemtuzumab Ozogamicin Drugs introduction, etc. Gemtuzumab Ozogamicin Drugs Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Gemtuzumab Ozogamicin Drugs
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Gemtuzumab Ozogamicin Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Gemtuzumab Ozogamicin Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 5mg/Vial
1.2.3 4.5mg/Vial
1.3 Market by Application
1.3.1 Global Gemtuzumab Ozogamicin Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gemtuzumab Ozogamicin Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Gemtuzumab Ozogamicin Drugs Revenue by Region
2.2.1 Global Gemtuzumab Ozogamicin Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Gemtuzumab Ozogamicin Drugs Revenue by Region (2018-2024)
2.2.3 Global Gemtuzumab Ozogamicin Drugs Revenue by Region (2024-2029)
2.2.4 Global Gemtuzumab Ozogamicin Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Gemtuzumab Ozogamicin Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Gemtuzumab Ozogamicin Drugs Sales by Region
2.4.1 Global Gemtuzumab Ozogamicin Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Gemtuzumab Ozogamicin Drugs Sales by Region (2018-2024)
2.4.3 Global Gemtuzumab Ozogamicin Drugs Sales by Region (2024-2029)
2.4.4 Global Gemtuzumab Ozogamicin Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Gemtuzumab Ozogamicin Drugs Sales by Manufacturers
3.1.1 Global Gemtuzumab Ozogamicin Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Gemtuzumab Ozogamicin Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gemtuzumab Ozogamicin Drugs in 2022
3.2 Global Gemtuzumab Ozogamicin Drugs Revenue by Manufacturers
3.2.1 Global Gemtuzumab Ozogamicin Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Gemtuzumab Ozogamicin Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Gemtuzumab Ozogamicin Drugs Revenue in 2022
3.3 Global Key Players of Gemtuzumab Ozogamicin Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Gemtuzumab Ozogamicin Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Gemtuzumab Ozogamicin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Gemtuzumab Ozogamicin Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Gemtuzumab Ozogamicin Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Gemtuzumab Ozogamicin Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Gemtuzumab Ozogamicin Drugs Sales by Type
4.1.1 Global Gemtuzumab Ozogamicin Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Gemtuzumab Ozogamicin Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Gemtuzumab Ozogamicin Drugs Sales Market Share by Type (2018-2029)
4.2 Global Gemtuzumab Ozogamicin Drugs Revenue by Type
4.2.1 Global Gemtuzumab Ozogamicin Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Gemtuzumab Ozogamicin Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Gemtuzumab Ozogamicin Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Gemtuzumab Ozogamicin Drugs Price by Type
4.3.1 Global Gemtuzumab Ozogamicin Drugs Price by Type (2018-2024)
4.3.2 Global Gemtuzumab Ozogamicin Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Gemtuzumab Ozogamicin Drugs Sales by Application
5.1.1 Global Gemtuzumab Ozogamicin Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Gemtuzumab Ozogamicin Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Gemtuzumab Ozogamicin Drugs Sales Market Share by Application (2018-2029)
5.2 Global Gemtuzumab Ozogamicin Drugs Revenue by Application
5.2.1 Global Gemtuzumab Ozogamicin Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Gemtuzumab Ozogamicin Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Gemtuzumab Ozogamicin Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Gemtuzumab Ozogamicin Drugs Price by Application
5.3.1 Global Gemtuzumab Ozogamicin Drugs Price by Application (2018-2024)
5.3.2 Global Gemtuzumab Ozogamicin Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Gemtuzumab Ozogamicin Drugs Market Size by Type
6.1.1 US & Canada Gemtuzumab Ozogamicin Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Gemtuzumab Ozogamicin Drugs Revenue by Type (2018-2029)
6.2 US & Canada Gemtuzumab Ozogamicin Drugs Market Size by Application
6.2.1 US & Canada Gemtuzumab Ozogamicin Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Gemtuzumab Ozogamicin Drugs Revenue by Application (2018-2029)
6.3 US & Canada Gemtuzumab Ozogamicin Drugs Market Size by Country
6.3.1 US & Canada Gemtuzumab Ozogamicin Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Gemtuzumab Ozogamicin Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Gemtuzumab Ozogamicin Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Gemtuzumab Ozogamicin Drugs Market Size by Type
7.1.1 Europe Gemtuzumab Ozogamicin Drugs Sales by Type (2018-2029)
7.1.2 Europe Gemtuzumab Ozogamicin Drugs Revenue by Type (2018-2029)
7.2 Europe Gemtuzumab Ozogamicin Drugs Market Size by Application
7.2.1 Europe Gemtuzumab Ozogamicin Drugs Sales by Application (2018-2029)
7.2.2 Europe Gemtuzumab Ozogamicin Drugs Revenue by Application (2018-2029)
7.3 Europe Gemtuzumab Ozogamicin Drugs Market Size by Country
7.3.1 Europe Gemtuzumab Ozogamicin Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Gemtuzumab Ozogamicin Drugs Sales by Country (2018-2029)
7.3.3 Europe Gemtuzumab Ozogamicin Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Gemtuzumab Ozogamicin Drugs Market Size
8.1.1 China Gemtuzumab Ozogamicin Drugs Sales (2018-2029)
8.1.2 China Gemtuzumab Ozogamicin Drugs Revenue (2018-2029)
8.2 China Gemtuzumab Ozogamicin Drugs Market Size by Application
8.2.1 China Gemtuzumab Ozogamicin Drugs Sales by Application (2018-2029)
8.2.2 China Gemtuzumab Ozogamicin Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Gemtuzumab Ozogamicin Drugs Market Size by Type
9.1.1 Asia Gemtuzumab Ozogamicin Drugs Sales by Type (2018-2029)
9.1.2 Asia Gemtuzumab Ozogamicin Drugs Revenue by Type (2018-2029)
9.2 Asia Gemtuzumab Ozogamicin Drugs Market Size by Application
9.2.1 Asia Gemtuzumab Ozogamicin Drugs Sales by Application (2018-2029)
9.2.2 Asia Gemtuzumab Ozogamicin Drugs Revenue by Application (2018-2029)
9.3 Asia Gemtuzumab Ozogamicin Drugs Sales by Region
9.3.1 Asia Gemtuzumab Ozogamicin Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Gemtuzumab Ozogamicin Drugs Revenue by Region (2018-2029)
9.3.3 Asia Gemtuzumab Ozogamicin Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Gemtuzumab Ozogamicin Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Gemtuzumab Ozogamicin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Gemtuzumab Ozogamicin Drugs Industry Chain Analysis
12.2 Gemtuzumab Ozogamicin Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gemtuzumab Ozogamicin Drugs Production Mode & Process
12.4 Gemtuzumab Ozogamicin Drugs Sales and Marketing
12.4.1 Gemtuzumab Ozogamicin Drugs Sales Channels
12.4.2 Gemtuzumab Ozogamicin Drugs Distributors
12.5 Gemtuzumab Ozogamicin Drugs Customers
13 Market Dynamics
13.1 Gemtuzumab Ozogamicin Drugs Industry Trends
13.2 Gemtuzumab Ozogamicin Drugs Market Drivers
13.3 Gemtuzumab Ozogamicin Drugs Market Challenges
13.4 Gemtuzumab Ozogamicin Drugs Market Restraints
14 Key Findings in The Global Gemtuzumab Ozogamicin Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Gemtuzumab Ozogamicin Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 5mg/Vial
Table 3. Major Manufacturers of 4.5mg/Vial
Table 4. Global Gemtuzumab Ozogamicin Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Gemtuzumab Ozogamicin Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Gemtuzumab Ozogamicin Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Gemtuzumab Ozogamicin Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Gemtuzumab Ozogamicin Drugs Revenue Market Share by Region (2018-2024)
Table 9. Global Gemtuzumab Ozogamicin Drugs Revenue Market Share by Region (2024-2029)
Table 10. Global Gemtuzumab Ozogamicin Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Gemtuzumab Ozogamicin Drugs Sales by Region (2018-2024) & (Units)
Table 12. Global Gemtuzumab Ozogamicin Drugs Sales by Region (2024-2029) & (Units)
Table 13. Global Gemtuzumab Ozogamicin Drugs Sales Market Share by Region (2018-2024)
Table 14. Global Gemtuzumab Ozogamicin Drugs Sales Market Share by Region (2024-2029)
Table 15. Global Gemtuzumab Ozogamicin Drugs Sales by Manufacturers (2018-2024) & (Units)
Table 16. Global Gemtuzumab Ozogamicin Drugs Sales Share by Manufacturers (2018-2024)
Table 17. Global Gemtuzumab Ozogamicin Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Gemtuzumab Ozogamicin Drugs Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Gemtuzumab Ozogamicin Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Gemtuzumab Ozogamicin Drugs Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Gemtuzumab Ozogamicin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Gemtuzumab Ozogamicin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gemtuzumab Ozogamicin Drugs as of 2022)
Table 23. Global Key Manufacturers of Gemtuzumab Ozogamicin Drugs, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Gemtuzumab Ozogamicin Drugs, Product Offered and Application
Table 25. Global Key Manufacturers of Gemtuzumab Ozogamicin Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Gemtuzumab Ozogamicin Drugs Sales by Type (2018-2024) & (Units)
Table 28. Global Gemtuzumab Ozogamicin Drugs Sales by Type (2024-2029) & (Units)
Table 29. Global Gemtuzumab Ozogamicin Drugs Sales Share by Type (2018-2024)
Table 30. Global Gemtuzumab Ozogamicin Drugs Sales Share by Type (2024-2029)
Table 31. Global Gemtuzumab Ozogamicin Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Gemtuzumab Ozogamicin Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Gemtuzumab Ozogamicin Drugs Revenue Share by Type (2018-2024)
Table 34. Global Gemtuzumab Ozogamicin Drugs Revenue Share by Type (2024-2029)
Table 35. Gemtuzumab Ozogamicin Drugs Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Gemtuzumab Ozogamicin Drugs Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Gemtuzumab Ozogamicin Drugs Sales by Application (2018-2024) & (Units)
Table 38. Global Gemtuzumab Ozogamicin Drugs Sales by Application (2024-2029) & (Units)
Table 39. Global Gemtuzumab Ozogamicin Drugs Sales Share by Application (2018-2024)
Table 40. Global Gemtuzumab Ozogamicin Drugs Sales Share by Application (2024-2029)
Table 41. Global Gemtuzumab Ozogamicin Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Gemtuzumab Ozogamicin Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Gemtuzumab Ozogamicin Drugs Revenue Share by Application (2018-2024)
Table 44. Global Gemtuzumab Ozogamicin Drugs Revenue Share by Application (2024-2029)
Table 45. Gemtuzumab Ozogamicin Drugs Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Gemtuzumab Ozogamicin Drugs Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Gemtuzumab Ozogamicin Drugs Sales by Type (2018-2024) & (Units)
Table 48. US & Canada Gemtuzumab Ozogamicin Drugs Sales by Type (2024-2029) & (Units)
Table 49. US & Canada Gemtuzumab Ozogamicin Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Gemtuzumab Ozogamicin Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Gemtuzumab Ozogamicin Drugs Sales by Application (2018-2024) & (Units)
Table 52. US & Canada Gemtuzumab Ozogamicin Drugs Sales by Application (2024-2029) & (Units)
Table 53. US & Canada Gemtuzumab Ozogamicin Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Gemtuzumab Ozogamicin Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Gemtuzumab Ozogamicin Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Gemtuzumab Ozogamicin Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Gemtuzumab Ozogamicin Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Gemtuzumab Ozogamicin Drugs Sales by Country (2018-2024) & (Units)
Table 59. US & Canada Gemtuzumab Ozogamicin Drugs Sales by Country (2024-2029) & (Units)
Table 60. Europe Gemtuzumab Ozogamicin Drugs Sales by Type (2018-2024) & (Units)
Table 61. Europe Gemtuzumab Ozogamicin Drugs Sales by Type (2024-2029) & (Units)
Table 62. Europe Gemtuzumab Ozogamicin Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Gemtuzumab Ozogamicin Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Gemtuzumab Ozogamicin Drugs Sales by Application (2018-2024) & (Units)
Table 65. Europe Gemtuzumab Ozogamicin Drugs Sales by Application (2024-2029) & (Units)
Table 66. Europe Gemtuzumab Ozogamicin Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Gemtuzumab Ozogamicin Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Gemtuzumab Ozogamicin Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Gemtuzumab Ozogamicin Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Gemtuzumab Ozogamicin Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Gemtuzumab Ozogamicin Drugs Sales by Country (2018-2024) & (Units)
Table 72. Europe Gemtuzumab Ozogamicin Drugs Sales by Country (2024-2029) & (Units)
Table 73. China Gemtuzumab Ozogamicin Drugs Sales by Type (2018-2024) & (Units)
Table 74. China Gemtuzumab Ozogamicin Drugs Sales by Type (2024-2029) & (Units)
Table 75. China Gemtuzumab Ozogamicin Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Gemtuzumab Ozogamicin Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Gemtuzumab Ozogamicin Drugs Sales by Application (2018-2024) & (Units)
Table 78. China Gemtuzumab Ozogamicin Drugs Sales by Application (2024-2029) & (Units)
Table 79. China Gemtuzumab Ozogamicin Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Gemtuzumab Ozogamicin Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Gemtuzumab Ozogamicin Drugs Sales by Type (2018-2024) & (Units)
Table 82. Asia Gemtuzumab Ozogamicin Drugs Sales by Type (2024-2029) & (Units)
Table 83. Asia Gemtuzumab Ozogamicin Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Gemtuzumab Ozogamicin Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Gemtuzumab Ozogamicin Drugs Sales by Application (2018-2024) & (Units)
Table 86. Asia Gemtuzumab Ozogamicin Drugs Sales by Application (2024-2029) & (Units)
Table 87. Asia Gemtuzumab Ozogamicin Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Gemtuzumab Ozogamicin Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Gemtuzumab Ozogamicin Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Gemtuzumab Ozogamicin Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Gemtuzumab Ozogamicin Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Gemtuzumab Ozogamicin Drugs Sales by Region (2018-2024) & (Units)
Table 93. Asia Gemtuzumab Ozogamicin Drugs Sales by Region (2024-2029) & (Units)
Table 94. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Sales by Type (2018-2024) & (Units)
Table 95. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Sales by Type (2024-2029) & (Units)
Table 96. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Sales by Application (2018-2024) & (Units)
Table 99. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Sales by Application (2024-2029) & (Units)
Table 100. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Sales by Country (2018-2024) & (Units)
Table 106. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Sales by Country (2024-2029) & (Units)
Table 107. Pfizer Company Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Gemtuzumab Ozogamicin Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer Gemtuzumab Ozogamicin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Gemtuzumab Ozogamicin Drugs Distributors List
Table 115. Gemtuzumab Ozogamicin Drugs Customers List
Table 116. Gemtuzumab Ozogamicin Drugs Market Trends
Table 117. Gemtuzumab Ozogamicin Drugs Market Drivers
Table 118. Gemtuzumab Ozogamicin Drugs Market Challenges
Table 119. Gemtuzumab Ozogamicin Drugs Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Gemtuzumab Ozogamicin Drugs Product Picture
Figure 2. Global Gemtuzumab Ozogamicin Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Gemtuzumab Ozogamicin Drugs Market Share by Type in 2022 & 2029
Figure 4. 5mg/Vial Product Picture
Figure 5. 4.5mg/Vial Product Picture
Figure 6. Global Gemtuzumab Ozogamicin Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Gemtuzumab Ozogamicin Drugs Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Gemtuzumab Ozogamicin Drugs Report Years Considered
Figure 11. Global Gemtuzumab Ozogamicin Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Gemtuzumab Ozogamicin Drugs Revenue 2018-2029 (US$ Million)
Figure 13. Global Gemtuzumab Ozogamicin Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Gemtuzumab Ozogamicin Drugs Revenue Market Share by Region (2018-2029)
Figure 15. Global Gemtuzumab Ozogamicin Drugs Sales 2018-2029 ((Units)
Figure 16. Global Gemtuzumab Ozogamicin Drugs Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Gemtuzumab Ozogamicin Drugs Sales YoY (2018-2029) & (Units)
Figure 18. US & Canada Gemtuzumab Ozogamicin Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Gemtuzumab Ozogamicin Drugs Sales YoY (2018-2029) & (Units)
Figure 20. Europe Gemtuzumab Ozogamicin Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Gemtuzumab Ozogamicin Drugs Sales YoY (2018-2029) & (Units)
Figure 22. China Gemtuzumab Ozogamicin Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Gemtuzumab Ozogamicin Drugs Sales YoY (2018-2029) & (Units)
Figure 24. Asia (excluding China) Gemtuzumab Ozogamicin Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Sales YoY (2018-2029) & (Units)
Figure 26. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Gemtuzumab Ozogamicin Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Gemtuzumab Ozogamicin Drugs in the World: Market Share by Gemtuzumab Ozogamicin Drugs Revenue in 2022
Figure 29. Global Gemtuzumab Ozogamicin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Gemtuzumab Ozogamicin Drugs Sales Market Share by Type (2018-2029)
Figure 31. Global Gemtuzumab Ozogamicin Drugs Revenue Market Share by Type (2018-2029)
Figure 32. Global Gemtuzumab Ozogamicin Drugs Sales Market Share by Application (2018-2029)
Figure 33. Global Gemtuzumab Ozogamicin Drugs Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Gemtuzumab Ozogamicin Drugs Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Gemtuzumab Ozogamicin Drugs Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Gemtuzumab Ozogamicin Drugs Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Gemtuzumab Ozogamicin Drugs Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Gemtuzumab Ozogamicin Drugs Revenue Share by Country (2018-2029)
Figure 39. US & Canada Gemtuzumab Ozogamicin Drugs Sales Share by Country (2018-2029)
Figure 40. U.S. Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Gemtuzumab Ozogamicin Drugs Sales Market Share by Type (2018-2029)
Figure 43. Europe Gemtuzumab Ozogamicin Drugs Revenue Market Share by Type (2018-2029)
Figure 44. Europe Gemtuzumab Ozogamicin Drugs Sales Market Share by Application (2018-2029)
Figure 45. Europe Gemtuzumab Ozogamicin Drugs Revenue Market Share by Application (2018-2029)
Figure 46. Europe Gemtuzumab Ozogamicin Drugs Revenue Share by Country (2018-2029)
Figure 47. Europe Gemtuzumab Ozogamicin Drugs Sales Share by Country (2018-2029)
Figure 48. Germany Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 49. France Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 50. UK Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. China Gemtuzumab Ozogamicin Drugs Sales Market Share by Type (2018-2029)
Figure 54. China Gemtuzumab Ozogamicin Drugs Revenue Market Share by Type (2018-2029)
Figure 55. China Gemtuzumab Ozogamicin Drugs Sales Market Share by Application (2018-2029)
Figure 56. China Gemtuzumab Ozogamicin Drugs Revenue Market Share by Application (2018-2029)
Figure 57. Asia Gemtuzumab Ozogamicin Drugs Sales Market Share by Type (2018-2029)
Figure 58. Asia Gemtuzumab Ozogamicin Drugs Revenue Market Share by Type (2018-2029)
Figure 59. Asia Gemtuzumab Ozogamicin Drugs Sales Market Share by Application (2018-2029)
Figure 60. Asia Gemtuzumab Ozogamicin Drugs Revenue Market Share by Application (2018-2029)
Figure 61. Asia Gemtuzumab Ozogamicin Drugs Revenue Share by Region (2018-2029)
Figure 62. Asia Gemtuzumab Ozogamicin Drugs Sales Share by Region (2018-2029)
Figure 63. Japan Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 67. India Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Gemtuzumab Ozogamicin Drugs Sales Share by Country (2018-2029)
Figure 74. Brazil Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Gemtuzumab Ozogamicin Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. Gemtuzumab Ozogamicin Drugs Value Chain
Figure 80. Gemtuzumab Ozogamicin Drugs Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed